Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 7 | $529,064 |
| Sells | 62 | $40,016,184 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 02 Oct 2024 18:53 | AMLX | Amylyx Pharmaceuticals Inc | KLEE JUSTIN B. | Co-Chief Executive Officer | 30 Sep 2024 | Sale | 18,589 | 3.197 | 59,429 | D |
| 02 Oct 2024 18:53 | AMLX | Amylyx Pharmaceuticals Inc | COHEN JOSHUA B | Co-Chief Executive Officer | 30 Sep 2024 | Sale | 18,589 | 3.1962 | 59,414 | D |
| 02 Oct 2024 18:50 | AMLX | Amylyx Pharmaceuticals Inc | BEDROSIAN CAMILLE L | Chief Medical Officer | 30 Sep 2024 | Sale | 11,442 | 3.1952 | 36,559 | D |
| 02 Oct 2024 18:48 | AMLX | Amylyx Pharmaceuticals Inc | MAZZARIELLO GINA | Chief Legal Officer | 30 Sep 2024 | Sale | 8,709 | 3.1967 | 27,840 | D |
| 16 Sep 2024 17:30 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 12 Sep 2024 | Purchase | 40,000 | 2.5342 | 101,368 | D |
| 09 Sep 2024 16:05 | AMLX | Amylyx Pharmaceuticals Inc | FIRESTONE KAREN | Director | 05 Sep 2024 | Purchase | 50,000 | 2.1318 | 106,590 | D |
| 05 Sep 2024 19:26 | AMLX | Amylyx Pharmaceuticals Inc | MILNE GEORGE M JR | Director | 03 Sep 2024 | Purchase | 100,000 | 2.198 | 219,800 | D |
| 16 May 2024 19:37 | AMLX | Amylyx Pharmaceuticals Inc | QUIMI DAPHNE | Director | 15 May 2024 | Purchase | 2,250 | 1.8899 | 4,252 | D |
| 16 May 2024 19:37 | AMLX | Amylyx Pharmaceuticals Inc | QUIMI DAPHNE | Director | 14 May 2024 | Purchase | 2,750 | 1.885 | 5,184 | D |
| 16 May 2024 19:36 | AMLX | Amylyx Pharmaceuticals Inc | MAZZARIELLO GINA | Chief Legal Officer | 15 May 2024 | Sale | 10,455 | 1.8799 | 19,654 | D |
| 07 Mar 2024 16:05 | AMLX | Amylyx Pharmaceuticals Inc | COHEN JOSHUA B | Co-Chief Executive Officer | 05 Mar 2024 | Sale | 4,135 | 18.7279 | 77,440 | D |
| 07 Mar 2024 16:05 | AMLX | Amylyx Pharmaceuticals Inc | KLEE JUSTIN B. | Co-Chief Executive Officer | 05 Mar 2024 | Sale | 4,135 | 18.7279 | 77,440 | D |
| 07 Mar 2024 16:05 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 05 Mar 2024 | Sale | 1,792 | 18.7279 | 33,560 | D |
| 07 Mar 2024 16:05 | AMLX | Amylyx Pharmaceuticals Inc | MAZZARIELLO GINA | Chief Legal Officer | 05 Mar 2024 | Sale | 1,540 | 18.7279 | 28,841 | D |
| 27 Feb 2024 17:59 | AMLX | Amylyx Pharmaceuticals Inc | MAZZARIELLO GINA | Chief Legal Officer | 23 Feb 2024 | Sale | 2,838 | 18.7564 | 53,231 | D |
| 11 Jan 2024 17:11 | AMLX | Amylyx Pharmaceuticals Inc | KLEE JUSTIN B. | Co-Chief Executive Officer | 09 Jan 2024 | Sale | 5,841 | 16.3281 | 95,372 | D |
| 11 Jan 2024 17:11 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 09 Jan 2024 | Sale | 2,716 | 16.3281 | 44,347 | D |
| 11 Jan 2024 17:10 | AMLX | Amylyx Pharmaceuticals Inc | COHEN JOSHUA B | Co-Chief Executive Officer | 09 Jan 2024 | Sale | 5,841 | 16.3281 | 95,372 | D |
| 11 Jan 2024 17:04 | AMLX | Amylyx Pharmaceuticals Inc | YERAMIAN PATRICK D | Chief Medical Officer | 09 Jan 2024 | Sale | 2,812 | 16.3281 | 45,915 | D |
| 19 Dec 2023 16:37 | AMLX | Amylyx Pharmaceuticals Inc | FIRESTONE KAREN | Director | 15 Dec 2023 | Purchase | 4,000 | 14.97 | 59,880 | D |
| 17 Aug 2023 16:35 | AMLX | Amylyx Pharmaceuticals Inc | MAZZARIELLO GINA | Chief Legal Officer | 15 Aug 2023 | Sale | 6,164 | 20.8771 | 128,686 | D |
| 18 May 2023 20:54 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 16 May 2023 | Sale | 500 | 27.6 | 13,800 | D |
| 18 May 2023 20:54 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 16 May 2023 | Sale | 32,000 | 26.9266 | 861,651 | D |
| 17 May 2023 16:58 | AMLX | Amylyx Pharmaceuticals Inc | YERAMIAN PATRICK D | Chief Medical Officer | 15 May 2023 | Sale | 11,965 | 29.0312 | 347,358 | D |
| 19 Apr 2023 19:45 | AMLX | Amylyx Pharmaceuticals Inc | YERAMIAN PATRICK D | Chief Medical Officer | 17 Apr 2023 | Sale | 300 | 30.94 | 9,282 | D |
| 19 Apr 2023 19:45 | AMLX | Amylyx Pharmaceuticals Inc | YERAMIAN PATRICK D | Chief Medical Officer | 17 Apr 2023 | Sale | 49,279 | 30.5335 | 1,504,660 | D |
| 31 Mar 2023 16:05 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 29 Mar 2023 | Sale | 29,048 | 30.45 | 884,512 | D |
| 29 Mar 2023 16:05 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 28 Mar 2023 | Sale | 100,000 | 30.37 | 3,037,000 | D |
| 29 Mar 2023 16:05 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 27 Mar 2023 | Sale | 28,000 | 30.8 | 862,400 | D |
| 29 Mar 2023 16:05 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 27 Mar 2023 | Sale | 32,964 | 30.25 | 997,161 | D |
| 24 Mar 2023 18:48 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 16 Mar 2023 | Sale A | 1,704 | 32.4649 | 55,320 | D |
| 24 Mar 2023 18:48 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 16 Mar 2023 | Sale A | 30,796 | 31.8593 | 981,139 | D |
| 24 Mar 2023 18:45 | AMLX | Amylyx Pharmaceuticals Inc | YERAMIAN PATRICK D | Chief Medical Officer | 16 Mar 2023 | Sale A | 2,416 | 32.4331 | 78,358 | D |
| 24 Mar 2023 18:45 | AMLX | Amylyx Pharmaceuticals Inc | YERAMIAN PATRICK D | Chief Medical Officer | 16 Mar 2023 | Sale A | 52,211 | 31.8485 | 1,662,842 | D |
| 23 Mar 2023 16:05 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 21 Mar 2023 | Sale | 28,807 | 32.17 | 926,721 | D |
| 23 Mar 2023 16:05 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 21 Mar 2023 | Sale | 34,641 | 31.69 | 1,097,773 | D |
| 20 Mar 2023 20:31 | AMLX | Amylyx Pharmaceuticals Inc | KLEE JUSTIN B. | Co-Chief Executive Officer | 16 Mar 2023 | Sale | 3,445 | 32.4751 | 111,877 | D |
| 20 Mar 2023 20:31 | AMLX | Amylyx Pharmaceuticals Inc | KLEE JUSTIN B. | Co-Chief Executive Officer | 16 Mar 2023 | Sale | 96,555 | 31.8405 | 3,074,359 | D |
| 20 Mar 2023 20:25 | AMLX | Amylyx Pharmaceuticals Inc | MILNE GEORGE M JR | Director | 16 Mar 2023 | Sale | 1,916 | 32.4487 | 62,172 | D |
| 20 Mar 2023 20:25 | AMLX | Amylyx Pharmaceuticals Inc | MILNE GEORGE M JR | Director | 16 Mar 2023 | Sale | 33,084 | 31.8553 | 1,053,901 | D |
| 20 Mar 2023 20:25 | AMLX | Amylyx Pharmaceuticals Inc | YERAMIAN PATRICK D | Chief Medical Officer | 16 Mar 2023 | Sale | 2,416 | 32.4331 | 78,358 | D |
| 20 Mar 2023 20:25 | AMLX | Amylyx Pharmaceuticals Inc | YERAMIAN PATRICK D | Chief Medical Officer | 16 Mar 2023 | Sale | 52,211 | 31.8485 | 1,662,842 | D |
| 20 Mar 2023 20:22 | AMLX | Amylyx Pharmaceuticals Inc | FIRESTONE KAREN | Director | 16 Mar 2023 | Purchase | 1,000 | 31.99 | 31,990 | D |
| 20 Mar 2023 20:21 | AMLX | Amylyx Pharmaceuticals Inc | COHEN JOSHUA B | Co-Chief Executive Officer | 16 Mar 2023 | Sale | 3,924 | 32.4451 | 127,315 | D |
| 20 Mar 2023 20:21 | AMLX | Amylyx Pharmaceuticals Inc | COHEN JOSHUA B | Co-Chief Executive Officer | 16 Mar 2023 | Sale | 96,076 | 31.8396 | 3,059,021 | D |
| 20 Mar 2023 20:18 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 16 Mar 2023 | Sale | 1,704 | 32.4649 | 55,320 | D |
| 20 Mar 2023 20:18 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 16 Mar 2023 | Sale | 30,796 | 31.8593 | 981,139 | D |
| 17 Mar 2023 16:05 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 16 Mar 2023 | Sale | 9,122 | 32.55 | 296,921 | D |
| 16 Mar 2023 16:11 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 15 Mar 2023 | Sale | 41,066 | 33.68 | 1,383,103 | D |
| 16 Mar 2023 16:11 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 15 Mar 2023 | Sale | 108,934 | 33.12 | 3,607,894 | D |
| 16 Mar 2023 16:11 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 14 Mar 2023 | Sale | 70,714 | 34.54 | 2,442,462 | D |
| 06 Mar 2023 09:10 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 02 Mar 2023 | Sale | 50,000 | 33.75 | 1,687,500 | D |
| 28 Feb 2023 16:42 | AMLX | Amylyx Pharmaceuticals Inc | MAZZARIELLO GINA | Chief Legal Officer | 24 Feb 2023 | Sale | 3,586 | 34.4874 | 123,672 | D |
| 28 Feb 2023 16:06 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 22 Feb 2023 | Sale | 2,112 | 35.34 | 74,638 | D |
| 28 Feb 2023 16:06 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 22 Feb 2023 | Sale | 47,888 | 34.7 | 1,661,714 | D |
| 24 Feb 2023 16:13 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 23 Feb 2023 | Sale | 1,111 | 36.24 | 40,263 | D |
| 24 Feb 2023 16:13 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 23 Feb 2023 | Sale | 48,889 | 35.55 | 1,738,004 | D |
| 24 Feb 2023 16:13 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 22 Feb 2023 | Sale | 10,084 | 36.34 | 366,453 | D |
| 24 Feb 2023 16:13 | AMLX | Amylyx Pharmaceuticals Inc | MORNINGSIDE VENTURE INVESTMENTS LTD | 10% | 22 Feb 2023 | Sale | 39,916 | 35.91 | 1,433,384 | D |
| 10 Jan 2023 19:22 | AMLX | Amylyx Pharmaceuticals Inc | YERAMIAN PATRICK D | Chief Medical Officer | 06 Jan 2023 | Sale | 629 | 36.7888 | 23,140 | D |
| 10 Jan 2023 19:22 | AMLX | Amylyx Pharmaceuticals Inc | YERAMIAN PATRICK D | Chief Medical Officer | 06 Jan 2023 | Sale | 1,405 | 36.0789 | 50,691 | D |
| 10 Jan 2023 19:20 | AMLX | Amylyx Pharmaceuticals Inc | COHEN JOSHUA B | Co-Chief Executive Officer | 06 Jan 2023 | Sale | 1,846 | 36.7888 | 67,912 | D |
| 10 Jan 2023 19:20 | AMLX | Amylyx Pharmaceuticals Inc | COHEN JOSHUA B | Co-Chief Executive Officer | 06 Jan 2023 | Sale | 4,122 | 36.0789 | 148,717 | D |
| 10 Jan 2023 19:20 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 06 Jan 2023 | Sale | 822 | 36.7888 | 30,240 | D |
| 10 Jan 2023 19:20 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 06 Jan 2023 | Sale | 1,836 | 36.0789 | 66,241 | D |
| 10 Jan 2023 19:19 | AMLX | Amylyx Pharmaceuticals Inc | OLINGER MARGARET | Chief Commercial Officer | 06 Jan 2023 | Sale | 743 | 36.7888 | 27,334 | D |
| 10 Jan 2023 19:19 | AMLX | Amylyx Pharmaceuticals Inc | OLINGER MARGARET | Chief Commercial Officer | 06 Jan 2023 | Sale | 1,660 | 36.0789 | 59,891 | D |
| 10 Jan 2023 19:12 | AMLX | Amylyx Pharmaceuticals Inc | KLEE JUSTIN B. | Co-Chief Executive Officer | 06 Jan 2023 | Sale | 1,846 | 36.7888 | 67,912 | D |
| 10 Jan 2023 19:12 | AMLX | Amylyx Pharmaceuticals Inc | KLEE JUSTIN B. | Co-Chief Executive Officer | 06 Jan 2023 | Sale | 4,122 | 36.0789 | 148,717 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)